Which Weight Management Treatment Offers Better Value?
Wegovy Cost Per Month vs Mounjaro: Price Comparison Breakdown
Understanding the Wegovy cost per month requires examining the five-dose escalation schedule compared to Mounjaro's six-dose progression. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and reaching £209.99 for the 2.4mg maintenance dose. The Wegovy cost per month becomes predictable at £209.99 once you reach the maintenance phase from week 17 onwards.
Mounjaro follows a different pricing structure with six available doses ranging from 2.5mg to 15mg, though the monthly cost varies based on your maintenance dose. Both treatments are prescription-only medicines requiring clinical assessment, but the Wegovy cost per month structure may be more straightforward for long-term budgeting. EverydayMeds offers bundle options for both treatments, with our Gentle Start Trio for Wegovy costing £269.99 and the Ultimate Stability Trio providing three months of 2.4mg maintenance for £649.99.
Clinical Mechanisms: Semaglutide vs Tirzepatide Approaches
The Wegovy cost per month reflects semaglutide's single GLP-1 receptor mechanism, whilst Mounjaro's pricing covers tirzepatide's dual GIP and GLP-1 receptor action. Wegovy works by mimicking the natural fullness hormone GLP-1, reducing appetite and promoting satiety after smaller meals. This may help reduce food cravings by working on brain appetite centres, supporting weight management when used alongside lifestyle modifications.
Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, potentially offering a different therapeutic approach to weight management. When considering Wegovy cost per month versus Mounjaro, the clinical mechanism difference means your prescriber will evaluate which treatment approach suits your individual circumstances. Both medications require gradual dose escalation and ongoing clinical monitoring, making the monthly cost consideration part of a longer-term treatment commitment.
Wegovy Cost Per Month: Bundle Savings and Discount Codes
EverydayMeds applies discount codes at checkout to reduce the effective Wegovy cost per month for both new and returning patients. New customers receive code FIRST40, whilst returning customers use DOSE25, bringing the starter dose to £79.99 after discount. Our Getting Started bundles combine multiple doses for treatment progression, with the Intro Duo (0.25mg & 0.5mg) costing £169.99 and the Progress Duo (0.5mg & 1mg) at £189.99.
The Consistency bundles provide two pens of the same strength for patients staying on a particular dose longer, potentially reducing the monthly Wegovy cost per month through fewer order transactions. The Consistency 2.4mg bundle costs £419.99 for two maintenance doses, whilst individual 2.4mg pens cost £209.99 each. Bundle pricing offers convenience benefits including fewer orders, Reliable Supply continuity, and single delivery arrangements through our temperature-controlled logistics network.
STEP Trial Evidence for Wegovy Monthly Treatment
Clinical evidence supporting the Wegovy cost per month comes from the landmark STEP trials published by Wilding et al. in NEJM, 2021. In clinical trials, patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo in STEP 1. The STEP 3 trial showed approximately clinically studied weight loss when combined with intensive behavioural therapy.
STEP 5 demonstrated sustained weight loss of approximately 15.2% at two years, supporting the long-term value proposition of the monthly Wegovy cost per month investment. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, adding clinical value beyond weight management for eligible patients.
How Wegovy Works to Justify Monthly Investment
The monthly Wegovy cost per month investment supports a sophisticated GLP-1 receptor agonist mechanism designed to address multiple aspects of appetite regulation. Semaglutide binds to GLP-1 receptors in the brain, stomach, and pancreas, promoting feelings of fullness and reducing the desire to eat large portions. This mechanism may help patients feel satisfied with smaller meals and experience reduced food cravings throughout the day. The once-weekly injection schedule using the FlexTouch pen device provides consistent medication levels, supporting steady appetite control between doses. Clinical studies suggest this mechanism works most effectively when combined with a reduced-calorie diet and increased physical activity, making the monthly investment part of a comprehensive weight management approach.
Ordering Process: From Assessment to Monthly Supply
Accessing your monthly Wegovy supply through EverydayMeds begins with a three-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-registered prescribers review your assessment within three working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, your Wegovy pens are dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) handles all prescribing and dispensing in compliance with UK regulations. Monthly re-orders follow a streamlined process, with automated reminders helping you maintain consistent treatment without interruption.
Storage and Practical Considerations for Monthly Costs
The Wegovy cost per month includes medications that require refrigeration at 2-8°C before first use, though pens can remain at room temperature below 30°C for up to six weeks once removed from the fridge. This storage flexibility provides significant advantages over Mounjaro, which only maintains stability for 21 days at room temperature, making Wegovy more suitable for frequent travellers or those with limited refrigeration access. Each pen contains four doses using Novo Nordisk's FlexTouch injection system, with clear dosing windows and simple operation. The mandatory dose escalation schedule means your monthly Wegovy cost per month increases gradually over the first 16 weeks before stabilising at the maintenance dose pricing. Proper storage ensures medication effectiveness and protects your monthly investment in treatment.
Wegovy vs Mounjaro: Monthly Cost Comparison for UK Patients
Direct comparison of Wegovy cost per month against Mounjaro reveals different pricing philosophies for these two weight management approaches. Wegovy's five-dose escalation reaches the £209.99 maintenance cost by week 17, providing predictable monthly expenses for long-term treatment planning. Mounjaro's six available doses may reach higher maintenance costs depending on the prescribed strength, though both treatments require similar clinical monitoring and assessment procedures.
The Wegovy cost per month structure may appeal to patients preferring predictable pricing, whilst Mounjaro's dosing flexibility might suit those requiring different therapeutic approaches. Both medications are available through EverydayMeds with the same clinical assessment process, next-day delivery, and ongoing prescriber support. Your choice between these treatments should consider clinical suitability alongside monthly costs, as both represent significant long-term financial commitments requiring sustained lifestyle modifications for optimal results.
Making Your Treatment Choice: Clinical and Financial Considerations
The final Wegovy cost per month represents an investment in a clinically proven weight management approach, with maintenance pricing of £209.99 providing access to weekly semaglutide injections and ongoing prescriber support. EverydayMeds stocks both Wegovy and Mounjaro, ensuring your prescriber can recommend the most clinically appropriate option regardless of cost considerations. Our discount codes FIRST40 for new customers and DOSE25 for returning patients are applied at checkout, reducing the effective monthly treatment cost. Both treatments remain prescription-only medicines requiring regular clinical review, making the relationship with your prescribing pharmacy crucial for long-term success. The monthly investment in either treatment works most effectively alongside sustainable dietary changes and increased physical activity, representing a comprehensive approach to weight management rather than a standalone solution. Compare both treatments and begin your clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
